307 results
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
7 Mar 24
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
8:32am
Securities Litigation Reform Act of 1995, regarding, among other things, Alimera’s expectations with respect to its business strategy, future
8-K
EX-10.1
ALIM
Alimera Sciences Inc.
9 Feb 24
Departure of Directors or Certain Officers
5:08pm
under any performance criterion to exclude any of the following events that occurs during a Performance Period: (a) asset write-downs, (b) litigation
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, Alimera’s expectations with respect
8-K
EX-99.1
326erb
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
8-K
EX-10.1
4pl036wjjzp7mn 4b
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
8-K
EX-99.1
apftt93cs43 rw8k5
8 Nov 23
Alimera Appoints Maggie A. Pax to Its Board of Directors
5:18pm
8-K
EX-99.1
9jl8a694
26 Oct 23
Alimera Sciences Reports Third Quarter 2023 Results
7:39am
8-K
EX-99.1
gdn9k688mp u8zdirf
3 Oct 23
Alimera Sciences Appoints Jason Werner as Chief Operating Officer
7:00am
8-K
EX-99.1
up7e4dm050vrhmpb92
10 Aug 23
Alimera Sciences Reports Second Quarter 2023 Results
8:44am
8-K
EX-10.2
3pm5fy
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
8-K
EX-10.1
uuykvwmbvjwf 2kno
2 Aug 23
Unregistered Sales of Equity Securities
5:18pm
424B3
m54 cedmf
12 Jul 23
Prospectus supplement
12:00am